Teachers Advisors’s Cidara Therapeutics CDTX Stock Holding History

Teachers Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,001	Closed	-$156K	–	3131
2017 Q1	$156K	Buy	1,001 +175	+21%	+$30.7K	﹤0.01%	2915
2016 Q4	$172K	Buy	826 +123	+17%	+$25.6K	﹤0.01%	2934
2016 Q3	$161K	Hold	703	–	–	﹤0.01%	2934
2016 Q2	$145K	Buy	703 +357	+103%	+$86.4K	﹤0.01%	2991
2016 Q1	$88K	Hold	346	–	–	﹤0.01%	2960
2015 Q4	$119K	Hold	346	–	–	﹤0.01%	2994
2015 Q3	$88K	Hold	346	–	–	﹤0.01%	3026
2015 Q2	$97K	Buy	+346	New	+$106K	﹤0.01%	3052

Other funds holding CDTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Teachers Advisors's CDTX Position: Q2 2017 in Review

Teachers Advisors sold out of Cidara Therapeutics (CDTX) in Q2 2017, closing a stake of 1,001 shares — an estimated $156K sold.

Teachers Advisors first reported a position in CDTX in Q2 2015 and held it in 8 quarters. The position peaked at $172K in Q4 2016. 54 funds tracked by Wall St. Rank hold CDTX as of Q2 2017.

Teachers Advisors reported no remaining Cidara Therapeutics position as of Q2 2017 after selling out during the quarter.
Teachers Advisors sold 1,001 Cidara Therapeutics shares in Q2 2017, an estimated $156K.
Teachers Advisors first reported a position in Cidara Therapeutics in Q2 2015 and held it in 8 quarters.
Teachers Advisors's Cidara Therapeutics position peaked at $172K in Q4 2016.
54 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.